Changeflow GovPing Courts & Legal GEVOKE Opposition Filed by Xeris Pharmaceuticals
Routine Notice Added Final

GEVOKE Opposition Filed by Xeris Pharmaceuticals

Favicon for changeflow.com TTAB Proceedings
Published
Detected
Email

Summary

Xeris Pharmaceuticals, Inc. filed TTAB Opposition No. 91306736 against TIANMING ZOU's GEVOKE trademark application with the USPTO Trademark Trial and Appeal Board on April 20, 2026. The opposition challenges registration of the GEVOKE mark by the individual applicant. TTAB oppositions are administrative proceedings where third parties seek to prevent registration of trademarks they believe should not be granted.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Xeris Pharmaceuticals filed a trademark opposition proceeding with the USPTO Trademark Trial and Appeal Board challenging registration of the GEVOKE mark by individual applicant TIANMING ZOU. The opposition has been assigned TTAB Proceeding No. 91306736.

Trademark oppositions are initiated by parties who believe they would be harmed by registration of the applied-for mark and seek to prevent the USPTO from registering it. Affected parties in trademark disputes should monitor TTAB proceedings that may affect their own trademark portfolios or applications.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO TTAB Proceedings

Opposition: GEVOKE

Opposition TTAB91306736-20260420 Kind: OPP Apr 20, 2026

Abstract

FILED AND FEE
Plaintiff: Xeris Pharmaceuticals, Inc.
Defendant: TIANMING ZOU
Mark at issue: GEVOKE

Filing Date

2026-04-20

View original document →

Get daily alerts for TTAB Proceedings

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 20th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TTAB91306736-20260420
Docket
91306736

Who this affects

Applies to
Legal professionals Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Trademark opposition Trademark registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare

Get alerts for this source

We'll email you when TTAB Proceedings publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!